Skip to main content
. Author manuscript; available in PMC: 2016 Apr 25.
Published in final edited form as: Gynecol Oncol. 2010 Dec 10;120(3):480–484. doi: 10.1016/j.ygyno.2010.11.016

Table 1.

Clinicopathologic characteristics.

N (%)

Total number of patients 266

Median age (range) 43 years (15–94)

Stage
 I 181 (68)
 II 18 (6.8)
 III/IV 67 (25.2)

Histology
 Serous 196 (73.7)
 Mucinous 64 (24.1)
 Clear cell 3 (1.1)
 Endometrioid 3 (1.1)

Lymphadenectomy
 Yes 128 (48.1)
 No 138 (51.9)
 Median lymph nodes sampled (range) 14.5 (1–45)

Adjuvant chemotherapy
 Yes 20 (7.5)
 No 249 (92.5)

Median follow-up (range) 3.7 years (0–22.8)

Status at last follow-up*
 NED 224 (84.2)
 AWD 15 (5.6)
 DOD 7 (2.6)
 DOO 17 (6)
 Lost to follow-up 3 (1.1)

Recurrence
 Yes 23 (8.6)
 No 243 (91.4)
*

NED = no evidence of disease, AWD = alive with disease, DOD = dead of disease, DOO = dead of other causes